IMUPURIN
IMUPURIN
COMMERCIAL NAME: IMUPURIN – food supplement manufactured according to the Rules of Good Manufacturing Practice of Medicines. Currently this product is approved as a medicine only in the CIS states.
PHARMACEUTICAL FORM: Hard gelatin capsules. The active component is Imupurin PB.
COMPOSITION: 1 capsule contains 150 mg Imupurin PB active substance. Excipients: potato starch, microcrystalline cellulose, lactose monohydrate, magnesium stearate, colloidal anhydrous silicon dioxide. talc, aerosil.
PRESENTATION: Hard, capped, opaque, cylindrical capsules with hemispherical ends, smooth and glossy surface, green body and cap, containing light brown to dark brown hygroscopic powder and granules.
PHARMACOLOGICAL PROPERTIES: Imupurin is a product with an immunomodulatory action, it stimulates the immunological reactivity and general resistance of the body, it intensifies the regenerative processes.
THERAPEUTIC INDICATIONS: Imupurin is recommended for adults as an immunomodulatory, adaptogenic and antioxidant remedy in endo- and exo-intoxication states with disorders of other organs, viral diseases, immunodeficiency states, decreased body resistance (asthenia, convalescence period, after chemotherapy and radiotherapy, etc.), in the complex treatment of infectious and inflammatory diseases with low cellular immunity, in slow regenerative processes (burns, trophic ulcers, ophthalmic herpes), in secondary immunodeficiency states with the predominant deregulation of humoral immunity.
CONTRAINDICATIONS: Gastric and duodenal ulcer in the acute phase, gastrointestinal bleeding, bronchial asthma, calculous cholecystitis, pregnancy and breastfeeding, hypersensitivity to the components of the drug.
DOSES AND METHOD OF ADMINISTRATION: Internally. 1 capsule 2 times a day, preferably in the morning and evening 1 hour before or 2 hours after breakfast and dinner. The duration of administration of the preparation is 3 months.
ADVERSE REACTIONS: Vertigo, fatigue, nausea, gastrointestinal disorders: rare – dyspepsia and diarrhea in the first days of use that disappear by themselves, allergic reactions.
OVERDOSE: Cases of overdose have not been reported.
WARNINGS AND SPECIAL PRECAUTIONS FOR USE: During the treatment, a dietary diet free of fatty foods and alcoholic beverages will be observed. Patients with rare hereditary problems of galactose intolerance, lactase deficiency (Lapp) or glucose-galactose malabsorption syndrome should not use this medicine.
PRESENTATION, PACKAGING: Cardboard box with 3 Al/PVC blisters, each containing 10 capsules, 150mg/capsule.
STORAGE: Store in a dry place away from light, temperatures below 25°C, in the original packaging. Do not freeze. Keep out of the sight and reach of children.
VALIDITY TERM: 2 years. Do not use after the expiry date indicated on the packaging.
